Dr Reddy's Gets EU Nod for Osteoporosis Drug AVT03
Dr Reddy's Laboratories secures European Commission marketing authorisation for AVT03, its denosumab biosimilar for osteoporosis treatment across EU markets. Learn about this major regulatory milestone.